ServiceNow (NOW) has gotten its technical act together and looks like it can make an assault on its July zenith. The stock survived a test of the rising 200-day moving average line earlier this month and now prices are knocking on an upside breakout.
More from Investing
No news can explain the action -- whether the bears believe it or not.
The last few post-earnings beat downs were greeted with optimism once traders got over the initial disappointment.
Forte's sole clinic candidate is FB-401 for the treatment of atopic dermatitis, which is the scientific name for eczema.